1. Ex-FDA Chief Gottlieb says regulator needs to up pace on COVID-19 drugs— Gilead won't be charging for use of experimental COVID drug, for now — FDA backs first emergency COVID-19 antibody test from Cellex — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Dave Santos

Discussion in 'Jazz Pharmaceuticals' started by anonymous, Mar 22, 2016 at 10:55 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

     

  2. anonymous

    anonymous Guest

    If you care to explain why your response is accurate, your voice might carry a bit more weight. Also, since you are posting on the Jazz board, you are an employee here as well. Are you calling yourself a reject?
     
  3. anonymous

    anonymous Guest


    He's all about himself. Worked with him at two different companies and what I can tell you is he lacks people skills, leadership, decision making skills and a realistic view of the business of oncology as it stands today. He routinely alienates even those who support him and as such has no followers, meaning no one leaves a company to go work with him - hence he cannot attract top talent. His reputation is awful at all the companies he has been at and failed to endear himself to anyone.

    Results are results, however based on my history with him, he has little to nothing to do with them either way. He's not good enough to drive results and he's not dumb enough to hurt them. I couldn't care less about his appearance, what I would say is he is one of the least charismatic people and public speakers I've encountered and is absolutely the least inspirational speaker or person for that matter. He does not foster an atmosphere of trust with his direct reports and will point the finger at the first sign of pressure - usually at the sales force or managers.

    Look, this shouldn't be news to you, but no one views Jazz as an "'A' player talent" company in the oncology space and as such it makes perfect sense for Jazz to be enthralled with his resume...no doubt he looks good on paper...once you get past that he has little talent, substance, or integrity. If you can, spend some time with him and form your own opinion...I know at least a hundred people that would agree with what is written above.
     
  4. anonymous

    anonymous Guest

    Even with supply fiasco we were still up. David is a driving force in the company and the defitelio and erwinaze hold proved he can overcome any obstacle. Santos's is incredibly well liked by his peers so don't fall for the malice by former disgruntled employees.
     
  5. anonymous

    anonymous Guest

    So not true. Funny, but not true. I do not know of anyone from Genentech who likes him. He is a fraud and those who know him know the truth. Glad you like him...probably explains why you are at Jazz.
     
  6. anonymous

    anonymous Guest

    I shouldn't admit this but I work at Jazz because I can't find another job, I don't work that hard and Jazz is technically oncology. We do have all the rejects of oncology but still on paper it's consistent. The funny thing about Dave is to watch the people who followed him here. They don't have a single chance to find another job so they suck up to him.
     
  7. anonymous

    anonymous Guest

    da plane da plane - little man is so cute.
     
  8. anonymous

    anonymous Guest

    He’s the best when he’s on stage. He needs a stepping stole. So adorable